[go: up one dir, main page]

AUPR713201A0 - Novel therapeutic molecules and uses therefor - Google Patents

Novel therapeutic molecules and uses therefor

Info

Publication number
AUPR713201A0
AUPR713201A0 AUPR7132A AUPR713201A AUPR713201A0 AU PR713201 A0 AUPR713201 A0 AU PR713201A0 AU PR7132 A AUPR7132 A AU PR7132A AU PR713201 A AUPR713201 A AU PR713201A AU PR713201 A0 AUPR713201 A0 AU PR713201A0
Authority
AU
Australia
Prior art keywords
novel therapeutic
therapeutic molecules
uses therefor
therefor
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR7132A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chua Kaw Yan
Original Assignee
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Singapore filed Critical National University of Singapore
Priority to AUPR7132A priority Critical patent/AUPR713201A0/en
Publication of AUPR713201A0 publication Critical patent/AUPR713201A0/en
Priority to PCT/AU2002/001125 priority patent/WO2003016529A1/en
Priority to MYPI20023076A priority patent/MY140636A/en
Assigned to CHEONG, NGE, CHUA, KAW YAN, LEE, BEE WAH reassignment CHEONG, NGE Assignment by Applicant under S 113 Assignors: NATIONAL UNIVERSITY OF SINGAPORE, THE
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43552—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects
    • G01N2333/43582—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects from mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AUPR7132A 2001-08-20 2001-08-20 Novel therapeutic molecules and uses therefor Abandoned AUPR713201A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPR7132A AUPR713201A0 (en) 2001-08-20 2001-08-20 Novel therapeutic molecules and uses therefor
PCT/AU2002/001125 WO2003016529A1 (en) 2001-08-20 2002-08-20 Novel blomia tropicalis antigens and uses therefor
MYPI20023076A MY140636A (en) 2001-08-20 2002-08-20 Protein allergen blo t1 from blomia tropicalis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR7132A AUPR713201A0 (en) 2001-08-20 2001-08-20 Novel therapeutic molecules and uses therefor

Publications (1)

Publication Number Publication Date
AUPR713201A0 true AUPR713201A0 (en) 2001-09-13

Family

ID=3831086

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR7132A Abandoned AUPR713201A0 (en) 2001-08-20 2001-08-20 Novel therapeutic molecules and uses therefor

Country Status (3)

Country Link
AU (1) AUPR713201A0 (en)
MY (1) MY140636A (en)
WO (1) WO2003016529A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070225207A1 (en) * 2004-04-23 2007-09-27 Novozymes A/S Group 1 Mite Polypeptide Variants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001029078A2 (en) * 1999-10-15 2001-04-26 Heska Corporation Method for production and use of mite group 1 proteins
NZ518487A (en) * 1999-10-26 2004-12-24 Kaw Yan Chua Immunogenic proteins from the domestic mite, blomia tropicalis

Also Published As

Publication number Publication date
MY140636A (en) 2010-01-15
WO2003016529A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002245332A1 (en) Anergy-regulated molecules
AU2002337312A1 (en) Molecules
AUPR535101A0 (en) Novel therapeutic molecules
AU2002327945A1 (en) Human delta-n p73 molecules and uses thereof
AU2002335667A1 (en) Modified reoviral therapy
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AUPR713201A0 (en) Novel therapeutic molecules and uses therefor
AUPR648901A0 (en) Novel therapeutic molecules and uses therefor
AUPP263498A0 (en) Novel therapeutic molecules and uses therefor
AUPR647401A0 (en) Novel therapeutic molecules and uses thereof
AUPR421601A0 (en) Therapeutic molecules and methods - 1B
AUPR463401A0 (en) Therapeutic molecules and methods - 2
AUPR496601A0 (en) Therapeutic molecules and methods - 3
AUPQ670400A0 (en) Novel therapeutic molecules and uses therefor
AUPR849001A0 (en) Immunointeractive molecules and uses thereof
AUPR073000A0 (en) Novel therapeutic molecules and uses therefor - iv
AUPR073200A0 (en) Novel therapeutic molecules and uses therefor - VI
AUPR073100A0 (en) Novel therapeutic molecules and uses therefor - vii
AUPQ884400A0 (en) Novel therapeutic molecules and uses therefor - II
AUPR073300A0 (en) Novel therapeutic molecules and uses therefor - V

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: KAW YAN CHUA, BEE WAH LEE, NGE CHEONG

Free format text: THE FORMER OWNER WAS: NATIONAL UNIVERSITY OF SINGAPORE